CA, M., P, M., S, S., J, B., JM, B., DS, M., . . . II, U. C. (2002). Lack of Benefit of Intravenous Synthetic Human Secretin in the Treatment of Autism. Journal of Autism & Developmental Disorders, 32(6), 545. https://doi.org/10.1023/a:1021202930206
Chicago Style (17th ed.) CitationCA, Molloy, Manning-Courtney P, Swayne S, Bean J, Brown JM, Murray DS, Kinsman AM, Brasington M, and Ulrich CD II. "Lack of Benefit of Intravenous Synthetic Human Secretin in the Treatment of Autism." Journal of Autism & Developmental Disorders 32, no. 6 (2002): 545. https://doi.org/10.1023/a:1021202930206.
MLA (9th ed.) CitationCA, Molloy, et al. "Lack of Benefit of Intravenous Synthetic Human Secretin in the Treatment of Autism." Journal of Autism & Developmental Disorders, vol. 32, no. 6, 2002, p. 545, https://doi.org/10.1023/a:1021202930206.